Lumera Labs Journal · Compendium
Retatrutide vs Tirzepatide: receptor-engagement comparison for research
Published 2024-02-19 · Lumera Labs Editorial · Kelowna, BC
Short answer. Tirzepatide engages two incretin receptors (GLP-1, GIP); Retatrutide adds the glucagon receptor for triple agonism, which broadens the downstream signaling pattern but complicates the pharmacology in cell-based screens.
Receptor engagement at a glance
| Compound | GLP-1R | GIPR | GCGR | Length |
|---|---|---|---|---|
| Semaglutide | ✓ | — | — | 30 res |
| Tirzepatide | ✓ | ✓ | — | 39 res |
| Retatrutide | ✓ | ✓ | ✓ | 39 res |
Why the third receptor matters in research
Glucagon receptor activation is hepatic-leaning: GCGR drives gluconeogenesis and lipolysis under physiological conditions, but in receptor-binding assays it changes the affinity panel a researcher needs to interpret. A clean Tirzepatide screen runs against two HEK293-receptor lines; Retatrutide work needs three.
Half-life and lipidation
Both peptides carry γGlu-C20 fatty-diacid modifications for albumin binding, producing comparable plasma half-lives (~five to seven days in published human PK). For in-vitro work this is irrelevant on the assay timescale, but it complicates translation interpretation in animal models.
What to verify on each COA
- Tirzepatide: ≥ 99% RP-HPLC, ESI-MS within 0.5 Da of 4813.45.
- Retatrutide: ≥ 99% RP-HPLC, ESI-MS within 0.5 Da of 4731.42.
- Both should show net peptide ≥ 80% by AAA and endotoxin < 0.5 EU/mg.
Stocking both
Researchers running a class-comparison study should source both from the same supplier in the same release window — different vendors layer in different counter-ion content and different storage history, making cross-class comparisons noisier than they need to be. Lumera ships Retatrutide from $45 CAD and Tirzepatide from $40 CAD with paired Janoshik COAs.
Lumera Labs ships HPLC-verified Retatrutide cold-chain across Canada from $45 CAD. View Retatrutide on the catalog →
Frequently asked questions
Which is more potent in vitro: Retatrutide or Tirzepatide?
Both bind their target receptors at low-nanomolar affinity in published assays. Direct comparison depends on the cell line and readout; Retatrutide's tri-receptor profile makes single-readout comparisons inadequate.
Can I run them in the same buffer?
Both reconstitute cleanly at neutral pH in bacteriostatic water. Use the same buffer composition across the comparison to avoid solvent-effect artifacts.
How do molecular weights compare?
Tirzepatide ~4813 Da, Retatrutide ~4731 Da. Both are 39-residue chains with C20 fatty-diacid modification.
Do they need separate cold-chain shipments?
No — both are stable lyophilized at −20 °C. Lumera ships them together in the same insulated package when ordered jointly.
Is there a tri-agonist with a different lipidation?
Several non-clinical tri-agonist scaffolds exist in the literature, but Retatrutide is the most-characterized clinically-translated example as of 2024.
Disclaimer: All Lumera Labs products are supplied for laboratory research use only. They are not approved by Health Canada for human consumption, therapy, or diagnosis. See our research-use declaration for full terms.